Literature DB >> 2103492

Metalloproteinases and cancer invasion.

L A Liotta1, W G Stetler-Stevenson.   

Abstract

The invasion and metastasis of cancer cells is a complex multistep process involving attachment of tumor cells to the basement membrane, proteolysis of the local connective tissue stroma, and migration through the proteolyzed stroma. Recent evidence implicates metalloproteinases such as type IV collagenase and transin/stromelysin in the proteolytic aspects of this process. Type IV collagenase activity is modulated by tissue inhibitors of metalloproteinases (TIMP-1 and TIMP-2). Immunohistochemical and biochemical studies of several human tumors show correlations between invasive potential and type IV collagenase activity.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2103492

Source DB:  PubMed          Journal:  Semin Cancer Biol        ISSN: 1044-579X            Impact factor:   15.707


  78 in total

1.  Fibroblast Enhancement of Tumor Invasion in a Tumor-Host Interface Recapitulated in-vitro.

Authors:  Robert A Gatenby; Elisabeth A Seftor; Mary JC Hendrix
Journal:  Pathol Oncol Res       Date:  1996       Impact factor: 3.201

2.  The significance of MMP-1 and MMP-2 in peritoneal disseminated metastasis of gastric cancer.

Authors:  K Mizutani; K Kofuji; K Shirouzu
Journal:  Surg Today       Date:  2000       Impact factor: 2.549

3.  Evidence for dissolution rate-limited absorption of COL-3, a matrix metalloproteinase inhibitor, leading to the irregular absorption profile in rats after oral administration.

Authors:  Jing Li; Hung Huynh; Eli Chan
Journal:  Pharm Res       Date:  2002-11       Impact factor: 4.200

4.  Human leucine zipper protein sLZIP induces migration and invasion of cervical cancer cells via expression of matrix metalloproteinase-9.

Authors:  Hyereen Kang; Sung-Wuk Jang; Jesang Ko
Journal:  J Biol Chem       Date:  2011-10-18       Impact factor: 5.157

5.  Expression of interleukin-8 correlates with angiogenesis, tumorigenicity, and metastasis of human prostate cancer cells implanted orthotopically in nude mice.

Authors:  S J Kim; H Uehara; T Karashima; M Mccarty; N Shih; I J Fidler
Journal:  Neoplasia       Date:  2001 Jan-Feb       Impact factor: 5.715

6.  Programmed cell death (apoptosis) in cord blood lymphocytes.

Authors:  S Aggarwal; A Gupta; S Nagata; S Gupta
Journal:  J Clin Immunol       Date:  1997-01       Impact factor: 8.317

7.  Direct evidence linking expression of matrix metalloproteinase 9 (92-kDa gelatinase/collagenase) to the metastatic phenotype in transformed rat embryo cells.

Authors:  E J Bernhard; S B Gruber; R J Muschel
Journal:  Proc Natl Acad Sci U S A       Date:  1994-05-10       Impact factor: 11.205

8.  Cloning and identification of genes differentially expressed in metastatic and non-metastatic rat rhabdomyosarcoma cell lines.

Authors:  L Daigneault; R Beaulieu; M Filion; L Gaboury; A Royal; F Babaï
Journal:  Clin Exp Metastasis       Date:  1995-09       Impact factor: 5.150

9.  Expressions of matrix metalloproteinase-7 and -9 and their prognostic significances in rectal cancer.

Authors:  Young Rak Cho; Hyuk-Chan Kwon; Sung-Hwan Suh; Jong Hoon Lee; Sung-Hyun Kim; Hong-Jo Choi; Hyung-Sik Lee; Mee Sook Roh; Tae-Ho Hwang; Jae-Seok Kim; Hyo-Jin Kim
Journal:  Cancer Res Treat       Date:  2005-12-31       Impact factor: 4.679

10.  Relation of matrilysin messenger RNA expression with invasive activity in human gastric cancer.

Authors:  A Senota; F Itoh; H Yamamoto; Y Adachi; Y Hinoda; K Imai
Journal:  Clin Exp Metastasis       Date:  1998-05       Impact factor: 5.150

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.